Download from app store
We have detected that you are using an Ad Blocker.
PracticeUpdate is free to end users but we rely on advertising to fund our site. Please consider supporting PracticeUpdate by whitelisting us in your ad blocker.
We have sent a message to the email address you have provided, . If this email is not correct, please update your settings with your correct address.
The email address you provided during registration, , does not appear to be valid. Please update your settings with a valid address before to continue using PracticeUpdate.
Please provide your AHPRA Number to ensure that you are given the correct level of access to our site.
Sign in
Join now
Josephine Harrington MD

Josephine Harrington MD

Cardiologist and Clinical Trialist, University of Colorado and the Colorado Prevention Center, Aurora, Colorado

Josephine Harrington, MD, is a cardiologist and clinical trialist at the University of Colorado and the Colorado Prevention Center. Her work focuses on the intersection of obesity and metabolic disease with heart failure and cardiovascular disease.

Disclosures

Dr. Harrington serves as a consultant for Novo Nordisk.

Recent Contributions to PracticeUpdate:

  1. Efficacy and Safety of SGLT2 Inhibitors With and Without GLP-1 Receptor Agonists
  2. Semaglutide in Patients With Obesity-Related Heart Failure and Type 2 Diabetes
  3. A Biomarker-Based Score for Risk of Hospitalization for Heart Failure in Patients With Diabetes

Most Read This Week

Recently Updated